Biologics Contract Manufacturing Market, By Service Type (Drug substance/Active Pharmaceutical Ingredient (API) Manufacturing, Drug product/Formulation and Fill-Finish (FDF), Analytical and Quality Control services, Process development and scale-up/Technology transfer, and Packaging, labeling and ancillary services), By Biologic Type (Monoclonal antibodies (mAbs), Recombinant proteins and enzymes, Vaccines, Cell and gene therapies, Antibody-drug conjugates (ADCs), and Others (growth factors, cytokines, fusion proteins)), By Production System (Mammalian systems (CHO, NS0, HEK), Microbial systems (E. coli, yeast), and Alternative/Emerging systems (insect cells, plant, cell-free)), By Scale (Preclinical/clinical scale manufacturing and Commercial scale manufacturing), By Company Size (Small to Mid-sized Contract Manufacturers and Large Contract Manufacturing Organizations (CMOs/CDMOs)), By Therapeutic Area (Oncology/Hematology, Immunology and Autoimmune Disorders, Infectious Diseases and Vaccinology, Cardiovascular and Renal Disorders, Neurology and Central Nervous System (CNS) Disorders, Metabolic and Endocrine Disorders (e.g., diabetes, obesity, thyroid), Respiratory Disorders, and Others (Dermatology, Rare and Orphan Diseases)), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)